Therapeutic TSOI Stock
Therapeutic Price Chart
Therapeutic TSOI Financial and Trading Overview
Therapeutic stock price | 0.0003 USD |
Previous Close | 0.0003 USD |
Open | 0.0002 USD |
Bid | 0.0002 USD x 0 |
Ask | 0.0003 USD x 0 |
Day's Range | 0.0002 - 0.0002 USD |
52 Week Range | 0.0001 - 0.0011 USD |
Volume | 20K USD |
Avg. Volume | 39.95M USD |
Market Cap | 1.02M USD |
Beta (5Y Monthly) | 1.238 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
TSOI Valuation Measures
Enterprise Value | 2.9M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 12.0083685 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 34.001 |
Enterprise Value/EBITDA | -0.884 |
Trading Information
Therapeutic Stock Price History
Beta (5Y Monthly) | 1.238 |
52-Week Change | -62.50% |
S&P500 52-Week Change | -2.46% |
52 Week High | 0.0011 USD |
52 Week Low | 0.0001 USD |
50-Day Moving Average | 0.000268 USD |
200-Day Moving Average | 0.00054205 USD |
TSOI Share Statistics
Avg. Volume (3 month) | 39.95M USD |
Avg. Daily Volume (10-Days) | 5.76M USD |
Shares Outstanding | 5.12B |
Float | 4.02B |
Short Ratio | N/A |
% Held by Insiders | 21.52% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2023 |
Most Recent Quarter (mrq) | September 30, 2024 |
Next Fiscal Year End | December 31, 2024 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -9963.49% |
Gross Margin | 65.80% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -63.49% |
Return on Equity (ttm) | -250.40% |
Income Statement
Revenue (ttm) | 85.32K USD |
Revenue Per Share (ttm) | 0 USD |
Quarterly Revenue Growth (yoy) | -23.59% |
Gross Profit (ttm) | 56.14K USD |
EBITDA | -3281793 USD |
Net Income Avi to Common (ttm) | -2410213 USD |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 9.23K USD |
Total Cash Per Share (mrq) | 0 USD |
Total Debt (mrq) | 929.63K USD |
Total Debt/Equity (mrq) | 55.28 USD |
Current Ratio (mrq) | 0.271 |
Book Value Per Share (mrq) | 0 |
Cash Flow Statement
Operating Cash Flow (ttm) | -484108 USD |
Levered Free Cash Flow (ttm) | 317.21K USD |
Profile of Therapeutic
Country | United States |
State | ID |
City | Elk City |
Address | 701 Wild Rose Lane |
ZIP | 83525 |
Phone | 760 295 7208 |
Website | https://www.therapeuticsolutionsint.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 3 |
Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production. It also produces nutraceuticals, including ProJuvenol, a synergistic blend of complex anti-aging ingredients in capsules; NanoStilbene, a nanoemulsion of nanoparticle pterostilbene; DermalStilbene, a topical form of pterostilbene delivered through spray application onto skin; IsoStilbene, an injectable formulation of pterostilbene; NeuroStilbene, an intranasal form of pterostilbene; NanoPSA, a blend of NanoStilbene and broccoli sprout extracts; and NLRP3 Trifecta, a two-product combo that consists of one bottle of NanoPSA and one bottle of GTE-50 green tea extract. In addition, the company develops therapeutics in chronic traumatic encephalopathy, and traumatic brain injury and lung pathology; and portfolio of immunotherapies that provides dendritic cell vaccines for cancers to Parkinson's disease developed on StemVacs platform. Therapeutic Solutions International, Inc. was founded in 2007 and is headquartered in Elk City, Idaho.
Q&A For Therapeutic Stock
What is a current TSOI stock price?
Therapeutic TSOI stock price today per share is 0.0003 USD.
How to purchase Therapeutic stock?
You can buy TSOI shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Therapeutic?
The stock symbol or ticker of Therapeutic is TSOI.
Which industry does the Therapeutic company belong to?
The Therapeutic industry is Biotechnology.
How many shares does Therapeutic have in circulation?
The max supply of Therapeutic shares is 5.12B.
What is Therapeutic Price to Earnings Ratio (PE Ratio)?
Therapeutic PE Ratio is now.
What was Therapeutic earnings per share over the trailing 12 months (TTM)?
Therapeutic EPS is 0 USD over the trailing 12 months.
Which sector does the Therapeutic company belong to?
The Therapeutic sector is Healthcare.